Twist Bioscience Corporation
TWST | NASDAQ
$134.13
-$18.65 (-12.21%)
Nov 2, 2026, 12:01 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -21.65 | -12.55 | -5.63 | -8.72 | -33.96 | -21.28 |
PEG Ratio | 0.34 | n/a | 0.52 | -0.31 | 2.89 | 2.38 |
PS Ratio | 4.47 | 8.38 | 4.70 | 9.33 | 39 | 33.04 |
PB Ratio | 3.56 | 5.55 | 1.85 | 2.41 | 8.89 | 8.85 |
P/FCF Ratio | -22.25 | -37.89 | -6.77 | -8.39 | -37.05 | -19.57 |
P/OCF Ratio | -35.34 | -40.90 | -8.09 | -15.27 | -45.98 | -20.93 |
OCF/S Ratio | -12.65 | -20.48 | -58.13 | -61.10 | -84.82 | -157.89 |
Debt / Equity Ratio | 0.29 | 0.18 | 0.15 | 0.12 | 0.11 | 0.11 |
Quick Ratio | 3.33 | 4.54 | 5.35 | 6.15 | 8.16 | 8.95 |
Current Ratio | 3.64 | 4.88 | 5.79 | 6.58 | 8.67 | 9.29 |
Asset Turnover | 0.59 | 0.51 | 0.32 | 0.21 | 0.19 | 0.23 |
Interest Coverage | n/a | -7.61K | -43.43K | -2.93K | -416.15 | -177.99 |
Return on Equity | -16.42% | -44.16% | -32.82% | -27.60% | -26.19% | -41.61% |
Return on Assets | -12.10% | -33.98% | -26.35% | -22.66% | -21.66% | -35.08% |
Return on Invested Capital | -24.15% | -39.57% | -30.25% | -25.34% | -23.24% | -37.60% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 50.72% | 42.61% | 36.61% | 41.38% | 39.08% | 31.85% |
Net Profit Margin | -20.63% | -66.69% | -83.48% | -107.02% | -114.94% | -155.31% |
Pretax Profit Margin | -20.43% | -66.51% | -83.01% | -112.14% | -116.39% | -154.88% |
Operating Profit Margin | -36.18% | -70.56% | -88.60% | -115.33% | -115.41% | -155.47% |
FCF Margin | -20.08% | -22.10% | -69.46% | -111.14% | -105.27% | -168.84% |
EBITDA Margin | -13.83% | -56.46% | -71.05% | -103.99% | -108.75% | -146.60% |
Add to Watchlist
Select watchlists to add or remove TWST